134 related articles for article (PubMed ID: 31523886)
21. Difficult clinical challenges in haemophilia: international experiential perspectives.
Forsyth AL; Giangrande P; Hay CR; Kenet G; Kessler CM; Knöbl PN; Llinás A; Santagostino E; Young G
Haemophilia; 2012 Jul; 18 Suppl 5():39-45. PubMed ID: 22757683
[TBL] [Abstract][Full Text] [Related]
22. Cryoglobulinaemia in haemophilia.
Lee CA; Kernoff PB; Peters DK
Br Med J (Clin Res Ed); 1985 Jun; 290(6486):1947-8. PubMed ID: 3924321
[No Abstract] [Full Text] [Related]
23. Arterial pseudoaneurysms in haemophilia: conservative treatment with observation and factor replacement.
Drew M; Yu JC; Michaels LA
Haemophilia; 2011 May; 17(3):550-2. PubMed ID: 21118336
[No Abstract] [Full Text] [Related]
24. FVIII replacement in 12-day-old newborn with haemophilia A requiring surgical repair of D transposition of great arteries.
Kuzmanovic M; Stajevic M; Vukomanovic V; Serbic O; Jankovic B
Haemophilia; 2011 Sep; 17(5):821-2. PubMed ID: 21435118
[No Abstract] [Full Text] [Related]
25. Clinical use of recombinant factor VIII Fc and recombinant factor IX Fc in patients with haemophilia A and B.
Wang C; Young G
Haemophilia; 2018 May; 24(3):414-419. PubMed ID: 29405496
[TBL] [Abstract][Full Text] [Related]
26. Prophylaxis in children with haemophilia - the Polish experience.
Klukowska A; Urasinski T; Janik-Moszant A; Bobrowska H; Balwierz W; Woznica-Karczmarz I; Dobaczewski G; Wlazlowski M; Koltan A; Badowska W; Dakowicz L; Karolczyk G; Kostrzewska M; Korczowski B; Wasinski D; Pietrys D; Laguna P; Wysocka M
Haemophilia; 2014 Jan; 20(1):e108-10. PubMed ID: 24251651
[No Abstract] [Full Text] [Related]
27. A pharmacokinetic model for factor VIII dosing during active haemorrhage in patients with haemophilia A.
Ho AM; Dion P; Karmakar MK; Cheng G; Derrick JL; Chung DC; Tay BA
Anaesthesia; 2001 Aug; 56(8):785-90. PubMed ID: 11493246
[TBL] [Abstract][Full Text] [Related]
28. Successful tracheal intubation using videolaryngoscope in Shwachman-Diamond syndrome patient combined with congenital epidermolysis bullosa.
Noda Y; Komasawa N; Matsunami S; Minami T
J Clin Anesth; 2019 Sep; 56():27. PubMed ID: 30684918
[No Abstract] [Full Text] [Related]
29. Purity of factor VIII product and incidence of inhibitors in previously untreated patients with haemophilia A.
Mauser-Bunschoten EP; van der Bom JG; Bongers M; Twijnstra M; Roosendaal G; Fischer K; van den Berg HM
Haemophilia; 2001 Jul; 7(4):364-8. PubMed ID: 11442640
[TBL] [Abstract][Full Text] [Related]
30. [A protocol for the orthopaedic prophylaxis in the rehabilitation of haemarthrosis in haemophilia A ].
Aznar JA; Miranda L; Espinosa C; Querol F; Martín G; Marty ML
Sangre (Barc); 1982; 27(2):156-64. PubMed ID: 6812226
[No Abstract] [Full Text] [Related]
31. Haemostatic response to factor VIII administration in patients with haemophilia A measured by thrombin generation and correlation with factor concentrate use.
Hugenholtz GC; Luddington R; Baglin T
Haemophilia; 2016 Jan; 22(1):e42-5. PubMed ID: 26388112
[No Abstract] [Full Text] [Related]
32. The use of agents that by-pass factor VIII inhibitors in patients with haemophilia.
Roberts HR
Vox Sang; 1999; 77 Suppl 1():38-41. PubMed ID: 10529686
[No Abstract] [Full Text] [Related]
33. Liver haemorrhage in haemophilia--a case report and review of the literature.
Hamilton M; French W; Rhymes N; Collins P
Haemophilia; 2006 Jul; 12(4):441-3. PubMed ID: 16834749
[TBL] [Abstract][Full Text] [Related]
34. Relationship between factor VIII replacement therapy and joint damage in severe haemophilia.
Lowe GD
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S3-5. PubMed ID: 9351528
[TBL] [Abstract][Full Text] [Related]
35. Reactivation of chronic hepatitis C virus infection by immunoadsorption in factor VIII inhibitor haemophilia.
Rommel F; Toepfer M; Eberle J; Schiffl H; Spannagl M; Schramm W
Thromb Haemost; 2000 Oct; 84(4):733-4. PubMed ID: 11057884
[No Abstract] [Full Text] [Related]
36. Pharmacokinetics of recombinant and plasma-derived factor VIII products in paediatric patients with severe haemophilia A.
Steele MR; Nagel K; Chan AK
Haemophilia; 2014 Jan; 20(1):e100-1. PubMed ID: 24251412
[No Abstract] [Full Text] [Related]
37. An inhibitor to factor VIII:C in a patient with possible combined haemophilia A and von Willebrand's disease.
Taylor LD; Dean FL; Tiedemann K; Ekert H
Thromb Haemost; 1986 Apr; 55(2):158-61. PubMed ID: 3087000
[TBL] [Abstract][Full Text] [Related]
38. Factor VIII--Baxter: rAHF-PFM, recombinant anti-haemophilic factor--protein-free method, recombinant factor VIII--protein-free.
Drugs R D; 2003; 4(6):366-8. PubMed ID: 14584967
[TBL] [Abstract][Full Text] [Related]
39. Continuous infusion of factor VIII concentrates in obese patients with severe haemophilia A: is weight-based dose-adjustment required?
Boban A; Henrard S; Lambert C; Hermans C
Haemophilia; 2016 Jan; 22(1):e62-4. PubMed ID: 26560746
[No Abstract] [Full Text] [Related]
40. [Production of factor VIII preparations and their use in the substitution therapy of hemophilia A].
Gaerisch F; Stein P
Z Gesamte Inn Med; 1982 Oct; 37(19):641-4. PubMed ID: 6817530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
